Correlation Between Medy Tox and Genexine
Can any of the company-specific risk be diversified away by investing in both Medy Tox and Genexine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medy Tox and Genexine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medy Tox and Genexine, you can compare the effects of market volatilities on Medy Tox and Genexine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medy Tox with a short position of Genexine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medy Tox and Genexine.
Diversification Opportunities for Medy Tox and Genexine
Weak diversification
The 3 months correlation between Medy and Genexine is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Medy Tox and Genexine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genexine and Medy Tox is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medy Tox are associated (or correlated) with Genexine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genexine has no effect on the direction of Medy Tox i.e., Medy Tox and Genexine go up and down completely randomly.
Pair Corralation between Medy Tox and Genexine
Assuming the 90 days trading horizon Medy Tox is expected to under-perform the Genexine. But the stock apears to be less risky and, when comparing its historical volatility, Medy Tox is 1.47 times less risky than Genexine. The stock trades about -0.14 of its potential returns per unit of risk. The Genexine is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 608,000 in Genexine on September 6, 2024 and sell it today you would lose (35,000) from holding Genexine or give up 5.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Medy Tox vs. Genexine
Performance |
Timeline |
Medy Tox |
Genexine |
Medy Tox and Genexine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Medy Tox and Genexine
The main advantage of trading using opposite Medy Tox and Genexine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medy Tox position performs unexpectedly, Genexine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genexine will offset losses from the drop in Genexine's long position.The idea behind Medy Tox and Genexine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Bonds Directory Find actively traded corporate debentures issued by US companies |